Logo image of OBAS

OPTIBASE LTD (OBAS) Stock Fundamental Analysis

NASDAQ:OBAS - Nasdaq - Common Stock

12.59  +0.46 (+3.79%)

After market: 12.23 -0.36 (-2.86%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to OBAS. OBAS was compared to 64 industry peers in the Real Estate Management & Development industry. OBAS has a bad profitability rating. Also its financial health evaluation is rather negative. OBAS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year OBAS was profitable.
OBAS Yearly Net Income VS EBIT VS OCF VS FCFOBAS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 0 2M -2M 4M 6M

1.2 Ratios

Industry RankSector Rank
ROA 2.74%
ROE 10.46%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OBAS Yearly ROA, ROE, ROICOBAS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 0 5 -5 10

1.3 Margins

Industry RankSector Rank
OM 39.31%
PM (TTM) 43.21%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OBAS Yearly Profit, Operating, Gross MarginsOBAS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 0 20 40 60 80

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, OBAS has about the same amount of shares outstanding.
Compared to 1 year ago, OBAS has an improved debt to assets ratio.
OBAS Yearly Shares OutstandingOBAS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 1M 2M 3M 4M 5M
OBAS Yearly Total Debt VS Total AssetsOBAS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 50M 100M 150M 200M 250M

2.2 Solvency

OBAS has an Altman-Z score of 0.15. This is a bad value and indicates that OBAS is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 1.84 is on the high side and indicates that OBAS has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 1.84
Debt/FCF N/A
Altman-Z 0.15
ROIC/WACCN/A
WACCN/A
OBAS Yearly LT Debt VS Equity VS FCFOBAS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 50M 100M 150M

2.3 Liquidity

OBAS has a Current Ratio of 2.58. This indicates that OBAS is financially healthy and has no problem in meeting its short term obligations.
OBAS has a Quick Ratio of 2.58. This indicates that OBAS is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 2.58
Quick Ratio 2.58
OBAS Yearly Current Assets VS Current LiabilitesOBAS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 10M 20M 30M 40M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 421.50% over the past year.
Measured over the past years, OBAS shows a very strong growth in Earnings Per Share. The EPS has been growing by 137.77% on average per year.
Looking at the last year, OBAS shows a decrease in Revenue. The Revenue has decreased by -7.86% in the last year.
OBAS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.53% yearly.
EPS 1Y (TTM)421.5%
EPS 3YN/A
EPS 5Y137.77%
EPS Q2Q%43.75%
Revenue 1Y (TTM)-7.86%
Revenue growth 3Y-3.58%
Revenue growth 5Y-0.53%
Sales Q2Q%-15.06%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OBAS Yearly Revenue VS EstimatesOBAS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 5M 10M 15M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 10.15 indicates a reasonable valuation of OBAS.
When comparing the Price/Earnings ratio of OBAS to the average of the S&P500 Index (27.93), we can say OBAS is valued rather cheaply.
Industry RankSector Rank
PE 10.15
Fwd PE N/A
OBAS Price Earnings VS Forward Price EarningsOBAS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.92
OBAS Per share dataOBAS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.07
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

OBAS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OPTIBASE LTD

NASDAQ:OBAS (3/22/2022, 8:23:17 PM)

After market: 12.23 -0.36 (-2.86%)

12.59

+0.46 (+3.79%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)11-30 2021-11-30/dmh
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap65.72M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP34.37%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 10.15
Fwd PE N/A
P/S 4.42
P/FCF N/A
P/OCF N/A
P/B 1.07
P/tB N/A
EV/EBITDA 15.92
EPS(TTM)1.24
EY9.85%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.85
BVpS11.78
TBVpSN/A
PEG (NY)N/A
PEG (5Y)0.07
Profitability
Industry RankSector Rank
ROA 2.74%
ROE 10.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 39.31%
PM (TTM) 43.21%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 1.84
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.58
Quick Ratio 2.58
Altman-Z 0.15
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)421.5%
EPS 3YN/A
EPS 5Y137.77%
EPS Q2Q%43.75%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.86%
Revenue growth 3Y-3.58%
Revenue growth 5Y-0.53%
Sales Q2Q%-15.06%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A